---
figid: PMC5142116__gr1
figlink: /pmc/articles/PMC5142116/figure/fig1/
number: F1
caption: Enzymes and Transporters Involved in Mammalian CNS PLP Synthesis and Homeostasis
  and Known Human Genetic Vitamin-B6-Dependent EpilepsiesPyridoxal 5′-phosphate (PLP);
  pyridoxamine 5′-phosphate (PMP); pyridoxal (PL); pyridoxine (PN); pyridoxine 5′-phosphate
  (PNP); pyridoxine-5′-β-D-glucoside (PNG); intestinal phosphatases (IP); transporter
  (identity unknown; T1); pyridoxal kinase (PK); pyridox(am)ine 5′-phosphate oxidase
  (PNPO); tissue non-specific alkaline phosphatase (TNSALP); pyridoxal-phosphatase
  (PLPase); aldehyde oxidase (Mo cofactor)/β-NAD dehydrogenase (AOX/DH). (1) PNPO
  is controlled by feedback inhibition from PLP. (2) PLP functions as a co-factor,
  forming Schiff bases with the ε-amino group of lysine residues of proteins. (3)
  PLP can be formed by recycling the cofactor from degraded enzymes (salvage pathway).
  (4) PLP levels are maintained, in part, by circadian-clock-controlled transcription
  factors with PAR bZip transcription factors (DBP, HLF, and TEF) targeting PK. (5)
  PNPO mutations cause a B6-dependent epilepsy disorder. (6) Disorders resulting in
  accumulation of L-Δ1-pyrroline-5-carboxylic acid (P5C) and Δ1-piperideine-6-carboxylic
  acid (P6C) (hyperprolinaemia type II and pyridoxine-dependent epilepsy due to mutations
  in ALDH4A1 and ALDH7A1, respectively) cause decreases in bioavailable PLP as do
  reactions with exogenous small molecules.
pmcid: PMC5142116
papertitle: Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and
  Cause Vitamin-B6-Dependent Epilepsy.
reftext: Niklas Darin, et al. Am J Hum Genet. 2016 Dec 1;99(6):1325-1337.
pmc_ranked_result_index: '174727'
pathway_score: 0.9532302
filename: gr1.jpg
figtitle: Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and
  Cause Vitamin-B6-Dependent Epilepsy.
year: '2016'
organisms:
- Homo sapiens
ndex: a2e5d272-deec-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5142116__gr1.html
  '@type': Dataset
  description: Enzymes and Transporters Involved in Mammalian CNS PLP Synthesis and
    Homeostasis and Known Human Genetic Vitamin-B6-Dependent EpilepsiesPyridoxal 5′-phosphate
    (PLP); pyridoxamine 5′-phosphate (PMP); pyridoxal (PL); pyridoxine (PN); pyridoxine
    5′-phosphate (PNP); pyridoxine-5′-β-D-glucoside (PNG); intestinal phosphatases
    (IP); transporter (identity unknown; T1); pyridoxal kinase (PK); pyridox(am)ine
    5′-phosphate oxidase (PNPO); tissue non-specific alkaline phosphatase (TNSALP);
    pyridoxal-phosphatase (PLPase); aldehyde oxidase (Mo cofactor)/β-NAD dehydrogenase
    (AOX/DH). (1) PNPO is controlled by feedback inhibition from PLP. (2) PLP functions
    as a co-factor, forming Schiff bases with the ε-amino group of lysine residues
    of proteins. (3) PLP can be formed by recycling the cofactor from degraded enzymes
    (salvage pathway). (4) PLP levels are maintained, in part, by circadian-clock-controlled
    transcription factors with PAR bZip transcription factors (DBP, HLF, and TEF)
    targeting PK. (5) PNPO mutations cause a B6-dependent epilepsy disorder. (6) Disorders
    resulting in accumulation of L-Δ1-pyrroline-5-carboxylic acid (P5C) and Δ1-piperideine-6-carboxylic
    acid (P6C) (hyperprolinaemia type II and pyridoxine-dependent epilepsy due to
    mutations in ALDH4A1 and ALDH7A1, respectively) cause decreases in bioavailable
    PLP as do reactions with exogenous small molecules.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HLF
  - PNPO
  - PPP1R14B
  - PLP1
  - CLOCK
  - TEF
  - PYCR1
  - DBP
  - ALPL
  - A4GALT
  - PNP
  - isoniazid
  - Lys
  - penicillamine
genes:
- word: HLF
  symbol: HLF
  source: hgnc_symbol
  hgnc_symbol: HLF
  entrez: '3131'
- word: PNPO
  symbol: PNPO
  source: hgnc_symbol
  hgnc_symbol: PNPO
  entrez: '55163'
- word: PNG
  symbol: PNG
  source: hgnc_alias_symbol
  hgnc_symbol: PPP1R14B
  entrez: '26472'
- word: PLP
  symbol: PLP
  source: hgnc_prev_symbol
  hgnc_symbol: PLP1
  entrez: '5354'
- word: Clock
  symbol: CLOCK
  source: hgnc_symbol
  hgnc_symbol: CLOCK
  entrez: '9575'
- word: TEF
  symbol: TEF
  source: hgnc_symbol
  hgnc_symbol: TEF
  entrez: '7008'
- word: P5C,
  symbol: P5C
  source: hgnc_alias_symbol
  hgnc_symbol: PYCR1
  entrez: '5831'
- word: DBP
  symbol: DBP
  source: hgnc_symbol
  hgnc_symbol: DBP
  entrez: '1628'
- word: TNSALP
  symbol: TNSALP
  source: hgnc_alias_symbol
  hgnc_symbol: ALPL
  entrez: '249'
- word: PK
  symbol: P(k)
  source: hgnc_alias_symbol
  hgnc_symbol: A4GALT
  entrez: '53947'
- word: PNP
  symbol: PNP
  source: hgnc_symbol
  hgnc_symbol: PNP
  entrez: '4860'
chemicals:
- word: isoniazid
  source: MESH
  identifier: D007538
- word: Lys
  source: MESH
  identifier: D008239
- word: penicillamine
  source: MESH
  identifier: D010396
diseases: []
figid_alias: PMC5142116__F1
redirect_from: /figures/PMC5142116__F1
figtype: Figure
---
